|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
|
US6913745B1
(en)
|
1997-12-02 |
2005-07-05 |
Neuralab Limited |
Passive immunization of Alzheimer's disease
|
|
US6923964B1
(en)
|
1997-12-02 |
2005-08-02 |
Neuralab Limited |
Active immunization of AScr for prion disorders
|
|
TWI239847B
(en)
*
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US6787523B1
(en)
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
|
US6750324B1
(en)
|
1997-12-02 |
2004-06-15 |
Neuralab Limited |
Humanized and chimeric N-terminal amyloid beta-antibodies
|
|
US7588766B1
(en)
|
2000-05-26 |
2009-09-15 |
Elan Pharma International Limited |
Treatment of amyloidogenic disease
|
|
US7790856B2
(en)
*
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
|
US20080050367A1
(en)
*
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
US6905686B1
(en)
|
1997-12-02 |
2005-06-14 |
Neuralab Limited |
Active immunization for treatment of alzheimer's disease
|
|
US6761888B1
(en)
*
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
|
US7179892B2
(en)
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
|
US20030147882A1
(en)
|
1998-05-21 |
2003-08-07 |
Alan Solomon |
Methods for amyloid removal using anti-amyloid antibodies
|
|
US7148324B1
(en)
*
|
1998-12-14 |
2006-12-12 |
Dendreon Corporation |
Compositions and methods for enhancement of major histocompatibility complex class I restricted antigen presentation
|
|
US6787637B1
(en)
|
1999-05-28 |
2004-09-07 |
Neuralab Limited |
N-Terminal amyloid-β antibodies
|
|
UA81216C2
(en)
*
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
|
HRP20020721B1
(en)
*
|
2000-02-21 |
2012-04-30 |
H. Lundbeck A/S |
Novel method for down-regulation of amyloid
|
|
WO2001062284A2
(en)
*
|
2000-02-21 |
2001-08-30 |
Pharmexa A/S |
Novel method for down-regulation of amyloid
|
|
AU2001268005A1
(en)
|
2000-07-07 |
2002-01-21 |
Lars Lannfelt |
Prevention and treatment of alzheimer's disease
|
|
PE20020574A1
(es)
*
|
2000-12-06 |
2002-07-02 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido amiloideo beta
|
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
|
US20040191264A1
(en)
*
|
2001-02-19 |
2004-09-30 |
Nielsen Klaus Gregorius |
Synthetic vaccine agents
|
|
US7097837B2
(en)
*
|
2001-02-19 |
2006-08-29 |
Pharmexa A/S |
Synthetic vaccine agents
|
|
US6815175B2
(en)
|
2001-03-16 |
2004-11-09 |
Cornell Research Foundation, Inc. |
Anti-amyloid peptide antibody based diagnosis and treatment of a neurological disease or disorder
|
|
WO2002074931A2
(en)
*
|
2001-03-20 |
2002-09-26 |
University Of Chicago |
Inhibitors and disassemblers of fibrillogenesis
|
|
MY144532A
(en)
*
|
2001-08-20 |
2011-09-30 |
Lundbeck & Co As H |
Novel method for down-regulation of amyloid
|
|
EP1572894B1
(en)
*
|
2001-11-21 |
2016-04-13 |
New York University |
Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha synuclein, or polyglutamine repeats for induction of an immune response thereto
|
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
CA2493119A1
(en)
*
|
2002-07-17 |
2004-01-22 |
Mindset Biopharmaceuticals Usa Inc. |
Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease
|
|
US7476509B2
(en)
*
|
2002-11-14 |
2009-01-13 |
Adherex Technologies Inc. |
Compounds and methods for modulating functions of nonclassical cadherins
|
|
AU2003303198A1
(en)
|
2002-12-19 |
2004-07-14 |
New York University |
Method for treating amyloid disease
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
GB0310270D0
(en)
*
|
2003-05-03 |
2003-06-11 |
Univ Edinburgh |
Biomolecular devices
|
|
TWI306458B
(en)
|
2003-05-30 |
2009-02-21 |
Elan Pharma Int Ltd |
Humanized antibodies that recognize beta amyloid peptide
|
|
SI2336147T1
(sl)
*
|
2003-12-17 |
2014-08-29 |
Janssen Alzheimer Immunotherapy |
Konjugati nosilcev a beta imunogenih peptidov in postopki izdelave istih
|
|
SE0401601D0
(sv)
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
|
KR20070100234A
(ko)
*
|
2004-10-06 |
2007-10-10 |
히로시 모리 |
변이형 아밀로이드 단백질
|
|
US20060257396A1
(en)
*
|
2004-12-15 |
2006-11-16 |
Jacobsen Jack S |
Abeta antibodies for use in improving cognition
|
|
EP1838348B1
(en)
|
2004-12-15 |
2013-06-26 |
Janssen Alzheimer Immunotherapy |
Humanized amyloid beta antibodies for use in improving cognition
|
|
ES2396555T3
(es)
*
|
2004-12-15 |
2013-02-22 |
Janssen Alzheimer Immunotherapy |
Anticuerpos que reconocen péptido beta amiloide
|
|
MX2007013725A
(es)
|
2005-05-05 |
2008-04-09 |
Sensient Flavors Inc |
Produccion de beta-glucanos y mananos.
|
|
PL1976877T5
(pl)
|
2005-11-30 |
2017-09-29 |
Abbvie Inc |
Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania
|
|
RU2442793C2
(ru)
|
2005-11-30 |
2012-02-20 |
Эбботт Лэборетриз |
АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ
|
|
MY169492A
(en)
|
2006-03-23 |
2019-04-15 |
Bioarctic Neuroscience Ab |
Improved protofibril selective antibodies and the use thereof
|
|
US8784810B2
(en)
*
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
WO2008021296A2
(en)
*
|
2006-08-14 |
2008-02-21 |
Thymon, L.L.C. |
Compositions and methods for the treatment and prophylaxis of alzheimer's disease
|
|
CA2660830A1
(en)
*
|
2006-08-14 |
2008-02-21 |
Gideon Goldstein |
Compositions and methods for the treatment and prophylaxis of multiple strains and subtypes of hiv-1
|
|
US8188046B2
(en)
|
2006-10-16 |
2012-05-29 |
University Of South Florida |
Amyloid beta peptides and methods of use
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
US8470325B2
(en)
*
|
2007-02-15 |
2013-06-25 |
Kagoshima University |
Method of treating amykloidosis comprising administering an anti-HMGB-1 antibody
|
|
WO2008099920A1
(ja)
*
|
2007-02-15 |
2008-08-21 |
Kyushu University, National University Corporation |
抗hmgb-1抗体を含む間質性肺疾患治療剤
|
|
JP5285437B2
(ja)
*
|
2007-02-15 |
2013-09-11 |
学校法人福岡大学 |
抗hmgb−1抗体を含む臓器移植拒絶抑制剤
|
|
US8895004B2
(en)
*
|
2007-02-27 |
2014-11-25 |
AbbVie Deutschland GmbH & Co. KG |
Method for the treatment of amyloidoses
|
|
WO2008106657A2
(en)
*
|
2007-03-01 |
2008-09-04 |
Intezyne Technologies, Inc. |
Encapsulated amyloid-beta peptides
|
|
WO2008131298A2
(en)
*
|
2007-04-18 |
2008-10-30 |
Elan Pharma International Limited |
Prevention and treatment of cerebral amyloid angiopathy
|
|
US8003097B2
(en)
*
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
|
ES2498040T3
(es)
|
2007-07-27 |
2014-09-24 |
Janssen Alzheimer Immunotherapy |
Tratamiento de enfermedades amiloidogénicas con anticuerpos anti-beta humanizados
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
AU2008322523B2
(en)
|
2007-11-16 |
2013-10-10 |
The Rockefeller University |
Antibodies specific for the protofibril form of beta-amyloid protein
|
|
US9045555B2
(en)
*
|
2008-07-01 |
2015-06-02 |
De Staat Der Nederlanden, Vert. Door De Minister Van Vws |
Vaccine against amyloid folding intermediate
|
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
|
TWI508976B
(zh)
*
|
2009-04-21 |
2015-11-21 |
Univ Rockefeller |
對β-類澱粉蛋白之基原纖維形式具專一性之抗體
|
|
US8409584B2
(en)
*
|
2009-05-05 |
2013-04-02 |
New York University |
Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins
|
|
EP4218794A3
(en)
*
|
2009-06-10 |
2023-09-13 |
New York University |
Immunological targeting of pathological tau proteins
|
|
CN101920008B
(zh)
*
|
2009-06-15 |
2013-07-31 |
浙江仙琚制药股份有限公司 |
包含Aβ40多肽和铝佐剂的制剂以及纯化Aβ40多肽的方法
|
|
WO2011130377A2
(en)
|
2010-04-15 |
2011-10-20 |
Abbott Laboratories |
Amyloid-beta binding proteins
|
|
US9062101B2
(en)
|
2010-08-14 |
2015-06-23 |
AbbVie Deutschland GmbH & Co. KG |
Amyloid-beta binding proteins
|
|
US9926353B2
(en)
|
2011-07-19 |
2018-03-27 |
New York University |
Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides
|
|
US8906382B2
(en)
|
2011-07-19 |
2014-12-09 |
New York University |
Method for treating amyloid disease
|
|
CN106661103B
(zh)
|
2014-07-10 |
2020-11-03 |
生命北极神经科学公司 |
改进的Aβ初原纤维结合抗体
|
|
US11970521B2
(en)
*
|
2016-08-20 |
2024-04-30 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Neuroprotective beta amyloid core peptides and peptidomimetic derivatives
|
|
CN119136838A
(zh)
|
2022-02-28 |
2024-12-13 |
特瑞德姆生物科技有限责任两合公司 |
由至少一种β-葡聚糖或甘露聚糖组成或包含至少一种β-葡聚糖或甘露聚糖的偶联物
|
|
JP2025507875A
(ja)
|
2022-02-28 |
2025-03-21 |
トライデム バイオサイエンス ゲーエムベーハー ウント コンパニー カーゲー |
少なくともβ-グルカン若しくはマンナンからなるか、又はこれを含む結合体
|